Preparation and evaluation of microemulsion-based transdermal delivery of total flavone of rhizoma arisaematis

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 3453-3464

  Shen, Li Na ^a   Zhang, Yong Tai ^a   Wang, Qin ^a   Xu, Ling ^a   Feng, Nian Ping ^a  

^a LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cellular uptake; Microemulsion; Nanocarrier; Transdermal

Indexed keywords

APIGENIN; CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; FLAVONE DERIVATIVE; ISOSCHAFTOSIDE; LAUROCAPRAM; OLEIC ACID ETHYL ESTER; SCHAFTOSIDE; UNCLASSIFIED DRUG; DRUG CARRIER; EMULSION; GLYCOSIDE; HERBACEOUS AGENT; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARISAEMA; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG PENETRATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; MICROEMULSION; MOUSE; NEW ZEALAND WHITE (RABBIT); NONHUMAN; NUDE MOUSE; RHIZOME; SCANNING ELECTRON MICROSCOPY; SKIN FIBROBLAST; SKIN IRRITATION; SKIN PENETRATION; SKIN PERMEABILITY; STRATUM CORNEUM; SUSPENSION; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; EMULSION; RAT; SKIN; SKIN ABSORPTION; SOLUBILITY; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; CELL LINE; DRUG CARRIERS; DRUGS, CHINESE HERBAL; EMULSIONS; GLYCOSIDES; HUMANS; MICE, NUDE; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN ABSORPTION; SOLUBILITY;

EID: 84905040912     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S66524     Document Type: Article

References (22)

1. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. Vol 1. Beijing: Chinese Pharmacopoeia Commission; 2010.
2. Huang CF, Yang RS, Liu SH, Hsieh PC, Lin-Shiau SY. Evidence for improved neuropharmacological efficacy and decreased neurotoxicity in mice with traditional processing of rhizoma arisaematis. Am J Chin Med. 2011; 39(5): 981-998.
3. El Maghraby GM. Microemulsions as transdermal drug delivery systems. Curr Nanosci. 2012; 8(4): 504-511.
4. Santos P, Watkinson AC, Hadgraft J, Lane ME. Application of microemulsions in dermal and transdermal drug delivery. Skin Pharmacol Physiol. 2008; 21(5): 246-259.
5. Lopes LB. Overcoming the cutaneous barrier with microemulsions. Pharmaceutics. 2014; 6(1): 52-77.
6. Mostafa DM, Ammar NM, Abd El-Alim SH, El-Anssary AA. Transdermal microemulsions of Glycyrrhiza glabra L.: characterization, stability and evaluation of antioxidant potential. Drug Deliv. 2014; 21(2): 130-139.
7. Chaiyana W, Rades T, Okonogi S. Characterization and in vitro permeation study of microemulsions and liquid crystalline systems containing the anticholinesterase alkaloidal extract from Tabernaemontana divaricata. Int J Pharm. 2013; 452(1-2): 201-210.
8. Azeem A, Khan ZI, Aqil M, Ahmad FJ, Khar RK, Talegaonkar S. Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm. 2009; 35(5): 525-547.
9. Akhter S, Jain GK, Ahmad FJ, et al. Investigation of nanoemulsion system for transdermal delivery of domperidone: ex-vivo and in vivo studies. Curr Nanosci. 2008; 4(4): 381-390.
10. Newby CS, Barr RM, Greaves MW, Mallet AI. Cytokine release and cytotoxicity in human keratinocytes and fibroblasts induced by phenols and sodium dodecyl sulfate. J Invest Dermatol. 2000; 115(2): 292-298.
11. Jung KM, Lee SH, Jang WH, et al. KeraSkin™-VM: A novel reconstructed human epidermis model for skin irritation tests. Toxicol In Vitro. 2014; 28(5): 742-750.
12. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS Pharm Sci Tech. 2007; 8(4): E104.
13. Yuan Y, Li SM, Mo FK, Zhong DF. Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm. 2006; 321(1-2): 117-123.
14. Thakkar PJ, Madan P, Lin S. Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation. Pharm Dev Technol. 2014; 19(3): 373-384.
15. Fouad SA, Basalious EB, El-Nabarawi MA, Tayel SA. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation. Int J Pharm. 2013; 453(2): 569-578.
16. Tashtoush BM, Bennamani AN, Al-Taani BM. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery. Pharm Dev Technol. 2013; 18(4): 834-843.
17. Rege BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci. 2002; 16(4-5): 237-246.
18. Zhao X, Liu JP, Zhang X, Li Y. Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharm. 2006; 327(1-2): 58-64.
19. Batheja P, Sheihet L, Kohn J, Singer AJ, Michniak-Kohn B. Topical drug delivery by a polymeric nanosphere gel: formulation optimization and in vitro and in vivo skin distribution studies. J Control Release. 2011; 149(2): 159-167.
20. Zhang YT, Zhao JH, Zhang SJ, et al. Enhanced transdermal delivery of evodiamine and rutaecarpine using microemulsion. Int J Nanomedicine. 2011; 6: 2469-2482.
21. Zhang YT, Huang ZB, Zhang SJ, et al. In vitro cellular uptake of evodiamine and rutaecarpine using a microemulsion. Int J Nanomedicine. 2012; 7: 2465-2472.
22. Hathout RM, Mansour S, Mortada ND, Geneidi AS, Guy RH. Uptake of microemulsion components into the stratum corneum and their molecular effects on skin barrier function. Mol Pharm. 2010; 7(4): 1266-1273.